Duke Clinical & Translational Science Institute
Overview
Duke Clinical & Translational Science Institute is an academic hub, supported by the NIH and Duke Health, that accelerates scientific discovery and translation by providing funding, resources, and education to advance research from concept to patient care.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tellus Therapeutics | Dec 2019 | Grant | Co-investor |
Key People
Sanyin Siang
Professor, Pratt School of Engineering, Founding Executive Director, Coach K Leadership & Ethics Center
Will Connelly
Principal Auditor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Duke Clinical & Translational Science Institute based?
Duke Clinical & Translational Science Institute is headquartered in Durham, North Carolina, United States.
When was Duke Clinical & Translational Science Institute founded?
Duke Clinical & Translational Science Institute was founded in 2006.
How many portfolio companies does Duke Clinical & Translational Science Institute have?
Duke Clinical & Translational Science Institute has 1 portfolio company in Caplight's dataset.
What are some companies in Duke Clinical & Translational Science Institute's portfolio?
Portfolio companies visible on Caplight include Tellus Therapeutics.
What was Duke Clinical & Translational Science Institute's most recent investment shown here?
Duke Clinical & Translational Science Institute's most recent investment in this portfolio sample was in Tellus Therapeutics in 2019.
What sectors does Duke Clinical & Translational Science Institute focus on?
Duke Clinical & Translational Science Institute focuses on Healthcare & Life Sciences.
What company stages does Duke Clinical & Translational Science Institute focus on?
Stage focus information for Duke Clinical & Translational Science Institute is not publicly available.